Academic Journal
ANMCO Position paper: Antithrombotic treatment of patients with atrial fibrillation and acute or chronic coronary syndromes undergoing coronary angioplasty with stent implantation
العنوان: | ANMCO Position paper: Antithrombotic treatment of patients with atrial fibrillation and acute or chronic coronary syndromes undergoing coronary angioplasty with stent implantation |
---|---|
المؤلفون: | De Luca L., Rubboli A., Lettino M., Tubaro M., Leonardi S., Casella G., Valente S., Rossini R., Sciahbasi A., Natale E., Trambaiolo P., Navazio A., Cipriani M., Corda M., De Nardo A., Francese G. M., Napoletano C., Tizzani E., Roncon L., Caldarola P., Riccio C., Gabrielli D., Oliva F., Gulizia M. M., Colivicchi F. |
المساهمون: | De Luca, L., Rubboli, A., Lettino, M., Tubaro, M., Leonardi, S., Casella, G., Valente, S., Rossini, R., Sciahbasi, A., Natale, E., Trambaiolo, P., Navazio, A., Cipriani, M., Corda, M., De Nardo, A., Francese, G. M., Napoletano, C., Tizzani, E., Roncon, L., Caldarola, P., Riccio, C., Gabrielli, D., Oliva, F., Gulizia, M. M., Colivicchi, F. |
سنة النشر: | 2022 |
المجموعة: | Università degli Studi di Siena: USiena air |
مصطلحات موضوعية: | Acute coronary syndrome, Antiplatelet therapy, Apixaban, Atrial fibrillation, Chronic coronary syndrome, Clopidogrel, Dabigatran, Direct oral anticoagulant, Edoxaban, Percutaneous coronary intervention, Rivaroxaban, Ticagrelor |
الوصف: | Patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with or without acute coronary syndromes (ACS) represent a subgroup with a challenging pharmacological management. Indeed, if on the one hand antithrombotic therapy should reduce the risk related to recurrent ischemic events and/or stent thrombosis, on the other hand care should be taken to avoid major bleeding events. In recent years, several trials, which overall included more than 12 000 patients, have been conducted demonstrating the safety of different therapeutic combinations of oral antiplatelet and anticoagulant agents. In the present ANMCO position paper we propose a decision-making algorithm on antithrombotic strategies based on scientific evidence and expert consensus to be adopted in the periprocedural phase, at the time of hospital discharge and in the long-term follow-up of patients with AF undergoing PCI with/without ACS. |
نوع الوثيقة: | article in journal/newspaper |
وصف الملف: | STAMPA |
اللغة: | Italian |
Relation: | info:eu-repo/semantics/altIdentifier/wos/WOS:000809423200009; volume:23; issue:5; firstpage:379; lastpage:395; numberofpages:17; journal:GIORNALE ITALIANO DI CARDIOLOGIA; https://hdl.handle.net/11365/1280087 |
DOI: | 10.1714/3796.37818 |
الاتاحة: | https://hdl.handle.net/11365/1280087 https://doi.org/10.1714/3796.37818 |
رقم الانضمام: | edsbas.BD1D0478 |
قاعدة البيانات: | BASE |
DOI: | 10.1714/3796.37818 |
---|